Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer-Reference-Cited by-同舟云学术

Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer

Published:2020-04-01 Issue:4 Volume:6 Page:547
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Petrelli Fausto¹,Labianca Roberto²,Zaniboni Alberto³,Lonardi Sara⁴,Galli Fabio⁵,Rulli Eliana⁵,Rosati Gerardo⁶,Corallo Salvatore⁷,Ronzoni Monica⁸,Cardellino Giovanni Gerardo⁹,Mattioli Rodolfo¹⁰,Mambrini Andrea¹¹,Ciuffreda Libero¹²,Banzi Maria¹³,Pusceddu Valeria¹⁴,Maiello Evaristo¹⁵,Zampino Maria¹⁶,Zagonel Vittorina⁴,Marchetti Paolo¹⁷,Corsi Domenico¹⁸,Rimassa Lorenza¹⁹,Cinieri Saverio²⁰,Sobrero Alberto²¹

Affiliation:

1. Medical Oncology Unit, Medical Science Department, American SamoaST Bergamo Ovest, Treviglio (BG), Italy

2. Cancer Center ASST Papa Giovanni XXIII, Bergamo, Italy

3. Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy

4. Medical Oncology Unit 1, Istituto Oncologico Veneto–IRCCS, Padova, Italy

5. Laboratory of Clinical Research Methodology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy

6. Medical Oncology Unit, Ospedale San Carlo, Potenza, Italy

7. Medical Oncology Unit, Fondazione Istituto Nazionale Tumori–IRCCS, Milano, Italy

8. Medical Oncology Unit, Ospedale San Raffaele–IRCCS, Milano, Italy

9. Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy

10. Medical Oncology Unit, Azienda Ospedaliera Santa Croce, Fano, Italy

11. Medical Oncology Unit Massa Carrara, Azienda Toscana Nordovest, Italy

12. Medical Oncology Unit, Azienda Ospedaliero Universitaria San Giovanni Battista, Molinette, Torino, Italy

13. Medical Oncology Unit, AUSL-IRCCS, Reggio Emilia, Italy

14. Medical Oncology, University Hospital and University of Cagliari, Cagliari, Italy

15. Medical Oncology Unit, Hospital Casa Sollievo della Sofferenza–IRCCS, San Giovanni Rotondo, Italy

16. Gastrointestinal Medical Oncology Unit and Neuroendocrine Tumors, Istituto Europeo di Oncologia–IRCCS, Milano, Italy

17. Medical Oncology Unit, Sant’Andrea Hospital, Sapienza University of Rome and IDI-IRCCS, Roma, Italy

18. Medical Oncology Unit Azienda Ospedaliera San Giovanni Calibita Fatebenefratelli Roma, Italy

19. Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano (Milano), Italy

20. Medical Oncology Unit, Ospedale di Summa A. Perrino Brindisi, Italy

21. Medical Oncology Unit, IRCCS San Martino-IST, Genova, Italy

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2761188/jamaoncology_petrelli_2020_br_190014.pdf

Reference14 articles.

1. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.;Gray;Lancet,2007

2. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.;Wilkinson;Ann Surg Oncol,2010

3. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study.;André;J Clin Oncol,2015

4. Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from modern-era adjuvant studies in the adjuvant colon cancer end points (ACCENT) database.;Shah;J Clin Oncol,2016

5. Treatment of patients with early-stage colorectal cancer: ASCO resource-stratified guideline.;Costas-Chavarri;J Glob Oncol,2019

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of chemoradiotherapy in IIA（T3N0M0）rectosigmoid junction cancer : a population-based study;2023-10-31

2. Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse;Journal of Translational Medicine;2023-08-05

3. Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies;Frontiers in Pharmacology;2023-08-01

4. A Critical Appraisal of Lipid Nanoparticles Deployed in Cancer Pharmacotherapy;Recent Advances in Drug Delivery and Formulation;2023-06

5. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system;Journal of Managed Care & Specialty Pharmacy;2023-06